The company commenced operations in 198889 with a single unit manufacturing semi-synthetic penicillin (SSP) in Puducherry.[8] Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. Aurobindo Pharma also has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues.[5] Aurobindo exports to over 125 countries with more than 70% of its revenues derived out of international operations.In 2014, Aurobindo purchased the generic operations of Actavis in 7 Western European countries for $41 million.[9][10]